Last Price$91.71.4%
Market Cap$18.6B
LTM EBIT to Interest coverage
5.5x
5Y avg
10.2x
Medical - Instruments & Supplies industry
median
(1.0x)
Stock quality & Intrinsic value
6/10
0.0% undervalued
The Cooper Companies, Inc. EBIT to Interest coverage
Annual
Quarterly
LTM
Industry median
Company stand-alone
Crunching data... Almost there!
| Oct'05 | Oct'06 | Oct'07 | Oct'08 | Oct'09 | Oct'10 | Oct'11 | Oct'12 | Oct'13 | Oct'14 | Oct'15 | Oct'16 | Oct'17 | Oct'18 | Oct'19 | Oct'20 | Oct'21 | Oct'22 | Oct'23 | Oct'24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EBIT to Interest coverage | 3.1x | 1.9x | 0.7x | 2.4x | 3.4x | 5.2x | 13.1x | 24.1x | 33.4x | 38.5x | 13.1x | 12.4x | 12.8x | 4.9x | 8.0x | 8.5x | 21.9x | 8.9x | 5.1x | 6.2x |
Overvalued or undervalued?
Check the intrinsic value for COO
and see if it's the right time to invest.
The Cooper Companies, Inc. (COO) EBIT to Interest coverage comparison analysis
General
LTM EBIT to Interest coverage
OTHER METRICS
Company name
Revenue growth
EPS growth
Net Income margin
The Cooper Companies, Inc.COO
5.5x
8.4%
32.2%
10.1%
Median Peer Set
8.7x
1.7%
15.9%
10.4%
West Pharmaceutical Services, Inc.WST
191.5x
(1.9%)
(15.5%)
17.0%
ResMed Inc.RMD
72.6x
10.9%
13.4%
21.8%
AptarGroup, Inc.ATR
23.9x
2.7%
30.2%
10.5%
Hologic, Inc.HOLX
14.7x
(0.0%)
81.1%
19.6%
Becton, Dickinson and CompanyBDX
10.1x
4.2%
18.3%
8.4%
Alcon Inc.ALC
7.4x
8.5%
182.9%
10.3%
Repligen CorporationRGEN
(0.3x)
(21.1%)
(80.9%)
5.6%
Baxter International Inc.BAX
(0.4x)
(69.5%)
(100.0%)
(6.9%)
Masimo CorporationMASI
(6.1x)
0.6%
(42.5%)
4.0%
Intuitive Surgical, Inc.ISRG
N/A
17.2%
27.7%
27.8%
COO key stats
USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
| Oct'05 | Oct'06 | Oct'07 | Oct'08 | Oct'09 | Oct'10 | Oct'11 | Oct'12 | Oct'13 | Oct'14 | Oct'15 | Oct'16 | Oct'17 | Oct'18 | Oct'19 | Oct'20 | Oct'21 | Oct'22 | Oct'23 | Oct'24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
% growth | 806.6 64.6% | 859.0 6.5% | 950.6 10.7% | 1,063.2 11.8% | 1,080.4 1.6% | 1,158.5 7.2% | 1,330.8 14.9% | 1,445.1 8.6% | 1,587.7 9.9% | 1,717.8 8.2% | 1,797.1 4.6% | 1,966.8 9.4% | 2,139.0 8.8% | 2,532.8 18.4% | 2,653.4 4.8% | 2,430.9 (8.4%) | 2,922.5 20.2% | 3,308.4 13.2% | 3,593.2 8.6% | 3,895.4 8.4% |
| Cost of Goods Sold (COGS) | 309.8 | 333.0 | 431.1 | 453.1 | 483.9 | 481.8 | 526.0 | 521.1 | 560.9 | 626.2 | 726.8 | 793.7 | 773.2 | 900.5 | 896.6 | 896.1 | 966.7 | 1,168.8 | 1,235.3 | 1,299.7 |
% margin | 496.8 61.6% | 526.0 61.2% | 519.5 54.7% | 610.0 57.4% | 596.5 55.2% | 676.7 58.4% | 804.8 60.5% | 924.0 63.9% | 1,026.8 64.7% | 1,091.6 63.5% | 1,070.3 59.6% | 1,173.1 59.6% | 1,365.8 63.9% | 1,632.3 64.4% | 1,756.8 66.2% | 1,534.8 63.1% | 1,955.8 66.9% | 2,139.6 64.7% | 2,357.9 65.6% | 2,595.7 66.6% |
| Operating Expenses | 352.5 | 406.7 | 464.0 | 481.5 | 442.8 | 486.4 | 577.2 | 635.6 | 685.7 | 785.1 | 833.6 | 849.0 | 936.7 | 1,204.8 | 1,229.1 | 1,223.0 | 1,450.0 | 1,632.0 | 1,824.8 | 1,890.0 |
| Research & Development Expenses (R&D) | 42.9 | 34.5 | 39.9 | 35.5 | 33.3 | 35.3 | 43.6 | 51.7 | 58.8 | 66.3 | 69.6 | 65.4 | 69.2 | 84.8 | 86.7 | 93.3 | 92.7 | 110.3 | 137.4 | 155.1 |
| Selling, General & Administrative Expenses (SG&A) | 298.0 | 357.8 | 408.0 | 429.3 | 391.6 | 433.1 | 513.1 | 559.9 | 596.7 | 683.1 | 712.5 | 722.8 | 799.1 | 973.3 | 996.6 | 992.5 | 1,211.2 | 1,342.2 | 1,501.2 | 1,533.7 |
% margin | 135.8 16.8% | 112.9 13.1% | 45.9 4.8% | 127.0 11.9% | 149.9 13.9% | 189.9 16.4% | 227.6 17.1% | 283.4 19.6% | 305.9 19.3% | 306.5 17.8% | 236.7 13.2% | 324.1 16.5% | 429.1 20.1% | 403.1 15.9% | 546.7 20.6% | 311.8 12.8% | 505.8 17.3% | 507.6 15.3% | 533.1 14.8% | 705.7 18.1% |
| Interest Income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Interest Expense | 43.6 | 58.7 | 67.5 | 53.8 | 44.1 | 36.7 | 17.3 | 11.8 | 9.2 | 8.0 | 18.1 | 26.2 | 33.4 | 82.7 | 68.0 | 36.8 | 23.1 | 57.3 | 105.3 | 114.3 |
| Pre-tax Income | 108.5 | 73.3 | 0.7 | 76.2 | 114.8 | 124.4 | 192.8 | 275.5 | 312.3 | 296.5 | 215.5 | 295.6 | 394.0 | 331.9 | 477.4 | 266.5 | 491.5 | 475.3 | 412.9 | 582.3 |
% effective tax rate | 16.7 15.4% | 7.1 9.7% | 11.9 1,765.5% | 10.7 14.1% | 14.3 12.4% | 11.6 9.3% | 17.3 9.0% | 26.8 9.7% | 15.4 4.9% | 24.7 8.3% | 10.3 4.8% | 20.7 7.0% | 21.1 5.4% | 192.0 57.8% | 10.7 2.2% | 28.1 10.5% | (2,453.2) (499.1%) | 89.5 18.8% | 118.7 28.7% | 190.0 32.6% |
% margin | 91.7 11.4% | 66.2 7.7% | (11.2) (1.2%) | 65.5 6.2% | 100.5 9.3% | 112.8 9.7% | 175.4 13.2% | 248.3 17.2% | 296.2 18.7% | 269.9 15.7% | 203.5 11.3% | 273.9 13.9% | 372.9 17.4% | 139.9 5.5% | 466.7 17.6% | 238.4 9.8% | 2,944.7 100.8% | 385.8 11.7% | 294.2 8.2% | 392.3 10.1% |
| EPS | 2.06 | 1.49 | (0.25) | 1.46 | 2.23 | 2.48 | 3.74 | 5.18 | 6.09 | 5.61 | 4.20 | 5.65 | 7.63 | 2.85 | 2.36 | 1.21 | 14.96 | 1.96 | 1.49 | 1.97 |
| Diluted EPS | 2.04 | 1.44 | (0.25) | 1.43 | 2.21 | 2.43 | 3.63 | 5.05 | 5.96 | 5.51 | 4.14 | 5.59 | 7.52 | 2.81 | 2.33 | 1.20 | 14.78 | 1.94 | 1.48 | 1.96 |
% margin | 133.0 16.5% | 168.2 19.6% | 127.0 13.4% | 206.3 19.4% | 238.6 22.1% | 244.9 21.1% | 305.4 22.9% | 398.4 27.6% | 446.8 28.1% | 442.7 25.8% | 425.0 23.6% | 520.1 26.4% | 613.6 28.7% | 689.7 27.2% | 826.2 31.1% | 622.9 25.6% | 863.7 29.6% | 908.6 27.5% | 885.9 24.7% | 705.7 18.1% |
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 35.3%
S&P Outperformance 22.3%
Next 3M Predicted Return 26.8%
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.
3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%
FAQ
1) What is The Cooper Companies, Inc.'s EBIT to Interest coverage?
As of today, Microsoft Corp's last 12-month EBIT to Interest coverage is 5.5x, based on the financial report for Oct 31, 2024 (Q4’2024). The average annual EBIT to Interest coverage for The Cooper Companies, Inc. have been 10.8x over the past three years, and 10.7x over the past five years.
2) Is The Cooper Companies, Inc.'s EBIT to Interest coverage Good?
As of today, The Cooper Companies, Inc.'s EBIT to Interest coverage is 5.5x, which is higher than industry median of (1.0x). It indicates that The Cooper Companies, Inc.'s EBIT to Interest coverage is Good.